Objectif
Neurodegenerative (ND) and neuromuscular (NM) disease is one of the most frequent classes of rare diseases, affecting life and mobility of 500,000 patients in Europe and millions of their caregivers, family members and employers. This NEUROMICS project brings together the leading research groups in Europe, five highly innovative SMEs and relevant oversea experts using the most sophisticated Omics technologies to revolutionize diagnostics and to develop pathomechanism-based treatment for ten major ND and NM diseases. Specifically we aim to:
(i) use next generation WES to increase the number of known gene loci for the most heterogeneous disease groups from about 50% to 80%,
(ii) increase patient cohorts by large scale genotyping by enriched gene variant panels and NGS of so far unclassified patients and subsequent phenotyping,
(iii) develop biomarkers for clinical application with a strong emphasis on presymptomatic utility and cohort stratification,
(iv) combine -omics approaches to better understand pathophysiology and identify therapeutic targets,
(v) identify disease modifiers in disease subgroups cohorts with extreme age of onset
(vi) develop targeted therapies (to groups or personalized) using antisense oligos and histone deacetylase inhibitors, translating the consortiums expertise in clinical development from ongoing trials toward other disease groups, notably the PolyQ diseases and other NMD.
To warrant that advances affect a large fraction of patients we limited the selection to a number of major categories, some of which are in a promising stage of etiological and therapeutic research while some others are in great need of further classification. The efforts will be connected through a NEUROMICS platform for impact, communication and innovation that will provide tools and procedures for ensuring trial-readiness, WP performance, sustainability, interaction with the chosen Support IRDiRC and RD-Connect project and involvement of stakeholders in the NDD/NMD field.
Champ scientifique
Appel à propositions
FP7-HEALTH-2012-INNOVATION-1
Voir d’autres projets de cet appel
Régime de financement
CP-IP - Large-scale integrating projectCoordinateur
72074 Tuebingen
Allemagne
Voir sur la carte
Participants (18)
2333 ZA Leiden
Voir sur la carte
50937 Koeln
Voir sur la carte
NE1 7RU Newcastle Upon Tyne
Voir sur la carte
53127 Bonn
Voir sur la carte
WC1E 6BT London
Voir sur la carte
13284 Marseille
Voir sur la carte
75654 Paris
Voir sur la carte
9052 ZWIJNAARDE - GENT
Voir sur la carte
20122 Milano
Voir sur la carte
44121 Ferrara
Voir sur la carte
CB2 1TN Cambridge
Voir sur la carte
101 Reykjavik
Voir sur la carte
20850 ROCKVILLE
Voir sur la carte
92100 BOULOGNE BILLANCOURT
Voir sur la carte
SE16494 KISTA
Voir sur la carte
6511 AA Nijmegen
Voir sur la carte
6009 Crawley
Voir sur la carte
79106 Freiburg
Voir sur la carte